Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-21-048714
Filing Date
2021-07-29
Accepted
2021-07-29 21:35:43
Documents
3
Period of Report
2021-07-29

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 7979
2 POA DOCUMENT poa.txt EX-24.3_1001123 3559
3 EX-24 DOCUMENT attachment1.htm EX-24 3736
  Complete submission text file 0001209191-21-048714.txt   17236
Mailing Address 10 ORINDA VIEW ROAD ORINDA CA 94563
Business Address
FAIRBAIRN EMILY (Reporting) CIK: 0001682638 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39692 | Film No.: 211129749

Mailing Address 79 MADISON AVENUE, 2ND FLOOR NEW YORK NY 10016
Business Address 79 MADISON AVENUE, 2ND FLOOR NEW YORK NY 10016 (646) 600-6438
IN8BIO, INC. (Issuer) CIK: 0001740279 (see all company filings)

EIN.: 825462585 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 10 ORINDA VIEW ROAD ORINDA CA 94563
Business Address 10 ORINDA VIEW ROAD ORINDA CA 94563 (646) 600-6438
Transcend Partners Opportunity Fund LLC (Reporting) CIK: 0001832019 (see all company filings)

State of Incorp.: CA | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-39692 | Film No.: 211129748